Your browser doesn't support javascript.
loading
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies.
Mateos, Maria-Victoria; Spencer, Andrew; Nooka, Ajay K; Pour, Ludek; Weisel, Katja; Cavo, Michele; Laubach, Jacob P; Cook, Gordon; Iida, Shinsuke; Benboubker, Lotfi; Usmani, Saad Z; Yoon, Sung-Soo; Bahlis, Nizar J; Chiu, Christopher; Ukropec, Jon; Schecter, Jordan M; Qin, Xiang; O'Rourke, Lisa; Dimopoulos, Meletios A.
Afiliação
  • Mateos MV; University Hospital of Salamanca/IBSAL, Salamanca, Spain mvmateos@usal.es.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia.
  • Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Pour L; University Hospital Brno, Brno, Czech Republic.
  • Weisel K; University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
  • Cavo M; Institute of Hematology Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Laubach JP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Cook G; St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, United Kingdom.
  • Iida S; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Bahlis NJ; Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada.
  • Chiu C; Janssen Research and Development, LLC, Spring House, PA, USA.
  • Ukropec J; Janssen Global Medical Affairs, Horsham, PA, USA.
  • Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Qin X; Janssen Research and Development, LLC, Spring House, PA, USA.
  • O'Rourke L; Janssen Research and Development, LLC, Spring House, PA, USA.
  • Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.
Haematologica ; 105(2): 468-477, 2020.
Article em En | MEDLINE | ID: mdl-31221782
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Mieloma Múltiplo Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Mieloma Múltiplo Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha